Compare BRO & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BRO | STE |
|---|---|---|
| Founded | 1939 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.6B | 24.5B |
| IPO Year | N/A | 1992 |
| Metric | BRO | STE |
|---|---|---|
| Price | $79.94 | $268.33 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 14 | 9 |
| Target Price | $97.93 | ★ $268.25 |
| AVG Volume (30 Days) | ★ 2.6M | 489.0K |
| Earning Date | 01-26-2026 | 02-04-2026 |
| Dividend Yield | 0.83% | ★ 0.94% |
| EPS Growth | N/A | ★ 59.39 |
| EPS | 3.31 | ★ 6.97 |
| Revenue | $5,350,000,000.00 | ★ $5,702,415,000.00 |
| Revenue This Year | $27.48 | $9.61 |
| Revenue Next Year | $23.16 | $6.23 |
| P/E Ratio | ★ $24.11 | $38.48 |
| Revenue Growth | ★ 17.50 | 7.08 |
| 52 Week Low | $76.17 | $204.90 |
| 52 Week High | $125.68 | $269.37 |
| Indicator | BRO | STE |
|---|---|---|
| Relative Strength Index (RSI) | 49.44 | 65.54 |
| Support Level | $78.54 | $256.51 |
| Resistance Level | $80.42 | $263.08 |
| Average True Range (ATR) | 1.77 | 5.55 |
| MACD | 0.04 | 1.33 |
| Stochastic Oscillator | 64.35 | 95.17 |
Brown & Brown Inc is a diversified insurance agency, wholesale brokerage, insurance programs, and service. The Company markets and sells insurance products and services, in the property, casualty, and employee benefits areas. It provides customers with non-investment insurance contracts, as well as other targeted, customized risk management products and services. It has four reportable segments; the Retail segment; the Programs segment; the Wholesale Brokerage segment and; the Services segment. It generates the majority of its revenue from the Retail segment which provides insurance products and services to commercial, public and quasi-public, and Others through automobile dealer services F&I businesses. Its geographic area is U.S., U.K., the Republic of Ireland, Canada, and Others.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.